Home

Thermometer Laden Gründe ara c doppelt wöchentlich Eifer

IJMS | Free Full-Text | Inhibitors of Chemoresistance Pathways in  Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini  Review
IJMS | Free Full-Text | Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review

Association of genetic polymorphisms in genes involved in Ara-C and dNTP  metabolism pathway with chemosensitivity and prognosis of adult acute  myeloid leukemia (AML) | Journal of Translational Medicine | Full Text
Association of genetic polymorphisms in genes involved in Ara-C and dNTP metabolism pathway with chemosensitivity and prognosis of adult acute myeloid leukemia (AML) | Journal of Translational Medicine | Full Text

Phase I and pharmacokinetic study of elacytarabine, a novel 5′-elaidic acid  derivative of cytarabine, in adults with refractory hematological  malignancies | Leukemia
Phase I and pharmacokinetic study of elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies | Leukemia

Cytarabine (Cytosine β-D-arabinofuranoside) | DNA Synthesis Inhibitor |  MedChemExpress
Cytarabine (Cytosine β-D-arabinofuranoside) | DNA Synthesis Inhibitor | MedChemExpress

Cytarabine Cytosine Arabinoside Arac Chemotherapy Drug: Stock-Vektorgrafik  (Lizenzfrei) 791676376 | Shutterstock
Cytarabine Cytosine Arabinoside Arac Chemotherapy Drug: Stock-Vektorgrafik (Lizenzfrei) 791676376 | Shutterstock

Cytarabine Cytosine Arabinoside Arac Chemotherapy Drug: Stockillustration  182516522 | Shutterstock
Cytarabine Cytosine Arabinoside Arac Chemotherapy Drug: Stockillustration 182516522 | Shutterstock

Structures of gemcitabine and ara-C (cytarabine). | Download Scientific  Diagram
Structures of gemcitabine and ara-C (cytarabine). | Download Scientific Diagram

Structures of gemcitabine and ara-C (cytarabine). | Download Scientific  Diagram
Structures of gemcitabine and ara-C (cytarabine). | Download Scientific Diagram

Structural insights into mutagenicity of anticancer nucleoside analog  cytarabine during replication by DNA polymerase η | Scientific Reports
Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports

Ara-C metabolism. Ara-C: Cytarabine; Ara-CDP: Ara-C diphosphate;... |  Download Scientific Diagram
Ara-C metabolism. Ara-C: Cytarabine; Ara-CDP: Ara-C diphosphate;... | Download Scientific Diagram

Cytarabin (cytosinarabinosid, Ara-c) Chemotherapie Medikament Molekül.  Verwendet In Der Behandlung Von Akuter Myeloischer Leukämie (aml), Akuter  Lymphatischer Leukämie (all) Und Lymphom. Konventionelles Skelettformel Und  Stilisierte Darstellungen ...
Cytarabin (cytosinarabinosid, Ara-c) Chemotherapie Medikament Molekül. Verwendet In Der Behandlung Von Akuter Myeloischer Leukämie (aml), Akuter Lymphatischer Leukämie (all) Und Lymphom. Konventionelles Skelettformel Und Stilisierte Darstellungen ...

Ara-C metabolism. Ara-C: Cytarabine; Ara-CDP: Ara-C diphosphate;... |  Download Scientific Diagram
Ara-C metabolism. Ara-C: Cytarabine; Ara-CDP: Ara-C diphosphate;... | Download Scientific Diagram

Cytarabine - an overview | ScienceDirect Topics
Cytarabine - an overview | ScienceDirect Topics

Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used  in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia  (AL Stock Vector Image & Art - Alamy
Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (AL Stock Vector Image & Art - Alamy

Stabilization of SAMHD1 by NONO is crucial for Ara-C resistance in AML |  Cell Death & Disease
Stabilization of SAMHD1 by NONO is crucial for Ara-C resistance in AML | Cell Death & Disease

Aracytidine, Ara-C Oligonucleotide Modification
Aracytidine, Ara-C Oligonucleotide Modification

The effects of cytarabine combined with ginsenoside compound K  synergistically induce DNA damage in acute myeloid leukemia cells -  ScienceDirect
The effects of cytarabine combined with ginsenoside compound K synergistically induce DNA damage in acute myeloid leukemia cells - ScienceDirect

RNA expression of genes involved in cytarabine metabolism and transport  predicts cytarabine response in acute myeloid leukemia | Pharmacogenomics
RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia | Pharmacogenomics

Structural insights into mutagenicity of anticancer nucleoside analog  cytarabine during replication by DNA polymerase η | Scientific Reports
Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports

Cytarabine - an overview | ScienceDirect Topics
Cytarabine - an overview | ScienceDirect Topics

High-Dose Ara-C with R-CHOP and Autologous Stem Cell Transplant (ASCT) in  Mantle-Cell Lymphoma | Research To Practice
High-Dose Ara-C with R-CHOP and Autologous Stem Cell Transplant (ASCT) in Mantle-Cell Lymphoma | Research To Practice

2'-Fluoro-2'-deoxy-ara-C(Bz)-3'-phosphoramidite | Cytidine Analog |  MedChemExpress
2'-Fluoro-2'-deoxy-ara-C(Bz)-3'-phosphoramidite | Cytidine Analog | MedChemExpress

Molecules | Free Full-Text | Exploring the Antitumor Mechanism of High-Dose  Cytarabine through the Metabolic Perturbations of Ribonucleotide and  Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells
Molecules | Free Full-Text | Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells

Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity  enhancing cytarabine efficacy | EMBO Molecular Medicine
Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy | EMBO Molecular Medicine

Sgc8 aptamer targeted glutathione-responsive nanoassemblies containing Ara-C  prodrug for the treatment of acute lymphoblastic leukemia - Nanoscale (RSC  Publishing)
Sgc8 aptamer targeted glutathione-responsive nanoassemblies containing Ara-C prodrug for the treatment of acute lymphoblastic leukemia - Nanoscale (RSC Publishing)